Abstract
Spermidine synthase (SPDS) is an important enzyme in the pathway for the biosynthesis of polyamines, and it synthesizes the polyamine spermidine from putrescine (PUT) and decarboxylated S-adenosylmethionine. This pathway is a promising target for antiproliferative therapies because of the functions of polyamines in cellular proliferation and differentiation. Higher polyamine levels are linked to cancer and cell proliferation. Previous structures of the enzyme were solved at cryogenic temperatures. Here, we report a new SPDS structure in complex with PUT (SPDS-PUT) and multitemperature crystallography of SPDS complexed with PUT and 5-deoxy-5-methylthioadenosine (MTA) at 100, 273, and 293 K to study its structure and dynamics. The results revealed that the occupancy of the active site is important for the extent of stabilization in the gatekeeping loop. The SPDS-PUT structure revealed putrescine binding in the absence of MTA, providing insight into its interactions within the active site and the conformational state of the gatekeeping loop. The binding of PUT alone was not enough to stabilize the gatekeeping loop, and greater stabilization of the loop occurred in the presence of MTA alone compared to PUT alone. The observed structural asymmetry between the gatekeeping loops of SPDS reflects differences in ligand binding between chains. These findings expand our understanding of the conformational landscape of SPDS.
I. INTRODUCTION
Polyamines are molecules containing two or more amino groups that perform significant functions in cells.1–5 The charge distribution of polyamines promotes interaction with diverse negatively charged biomolecules such as proteins, nucleic acids, and acidic phospholipids.5–7 Polyamines are crucial for stabilizing DNA and RNA, playing vital roles in cellular development, stress responses, and regulation of genes, hence rendering them important in both pathological and physiological conditions.1,6,8–11 They perform pleiotropic roles in cellular processes such as redox equilibrium important for cell-to-cell communication, immunity, adhesion of cells, synthesis of proteins, proliferation, extracellular matrix repair, autophagy, and many types of cell death.12–19 Intracellular polyamine concentrations must be tightly controlled because of their pleiotropic role, ensuring a careful balance between transport, biosynthesis, and degradation. Accordingly, polyamine biosynthetic enzymes are tightly regulated at different levels, such as transcription, translation, and post-translational modification.19
The main pathway for the biosynthesis of polyamines involves the enzymes ornithine decarboxylase, spermidine synthase (SPDS), spermine synthase, and S-adenosylmethionine decarboxylase (AdoMetDC) and involves the decarboxylation of ornithine and aminopropyl transfer reactions to produce PUT, spermidine, and spermine.5,20–22 Given the essential roles of the polyamine biosynthetic pathway and its involvement in numerous diseases, this pathway is an important target for therapeutic research. The metabolism of polyamines is often dysregulated in cancer, suggesting that increased polyamine levels are essential for cellular transformation and tumor growth.12,20,23 It has also been demonstrated that spermidine is essential for malignant transformation, proliferation, and MYC (MYC proto-oncogene) expression.24–26 The dysregulation of polyamine metabolism has been implicated in several malignancies, including breast, colorectal, prostate, and skin cancers, highlighting the importance of the pathway as a therapeutic and chemopreventive target. Thus, polyamines and their metabolic derivatives are considered biomarkers of cancer.5,27–31
Spermidine synthase (SPDS) is an essential enzyme in the polyamine biosynthetic pathway, and it catalyzes the transfer of an aminopropyl group to putrescine (PUT) to produce spermidine, a polyamine, and 5-deoxy-5-methylthioadenosine (MTA) as a by-product. The catalytic residue, Asp173, deprotonates the N1 amine of PUT, thus performing a nucleophilic attack on the carbon next to the sulfonium center on the aminopropyl group. The reaction is also stabilized by the conserved amino acid residue, the backbone carbonyl of Ser174, and the hydroxyl groups of Tyr79 and Tyr241. The reaction is completed as the aminopropyl group is transferred to PUT and the electron pair gets transferred to the sulfur atom, producing spermidine and MTA (Fig. S1). The aminopropyl group from decarboxylated S-adenosylmethionine (dcAdoMet) is synthesized by AdoMetDC, which is a rate-limiting enzyme for the production of spermidine. Spermidine is one of the major polyamines essential for cell growth and development.2,32–36 It is involved in several biological roles, including suppressing nitric oxide, modulating membrane potential, and stimulating autophagy. Also, the elF5A initiation factor requires an aminobutyl group from spermidine for its posttranslational modification. The first process relies on spermidine, which donates the 4-aminobutyl group that is intended to bind to eIF5A's lysine amino group, thus generating deoxyhypusine, an intermediate. Subsequently, hypusine is generated by the hydroxylation of the intermediate.37–40
The structure of human SPDS is a homodimer composed of the N-terminal domain, the central core domain, and the C-terminal domain (Fig. 1). The dimerization interface is formed by the N-terminal and C-terminal domains, and the active site is in between the N-terminal and central core domains, consisting of both the dcAdoMet and PUT binding pockets.2,34,36 The gatekeeping loop contains a short alpha helix, and it is positioned near the active site entrance, enclosing the catalytic pockets.2,32,34,36 This flexible loop is completely disordered in apo human SPDS, as in other apo homologous SPDS structures.2,4,32,41–44 However, it is ordered in ligand-bound structures. The loop is also stabilized in the presence of PUT, as demonstrated by the comparison of the structure of the SPDS-MTA complex with that of SPDS-MTA-PUT.36
FIG. 1.

Structural overview of SPDS. SPDS consists of two chains, each containing N-terminal, central core, and C-terminal domains. The active site is located between the N-terminal and central core domains and contains the putrescine and aminopropyl donor binding pockets (green) and a gatekeeping loop (red).
Multitemperature crystallography of SPDS was performed to probe the structural transitions of the enzyme at different temperatures, 100, 273, and 293 K. At cryogenic temperatures, conformations of the side and main chains of enzymes have been reported to be hidden or altered.45–49 Previously unknown conformations have been discovered through crystal structure determination at room temperature. Regions of the protein were observed to change from having one conformation to several conformations with an increase in temperature.48,50–58 The structures of AdoMetDC collected at ambient temperature showed a different conformation of the DL2 (disordered loop 2) region compared to the structure determined at cryogenic temperature.21 Thus, the structure of SPDS was solved at 100, 273, and 293 K to study the temperature dependence of the enzyme. The multitemperature structures allowed for investigation of possible asymmetry between the two chains of SPDS. Multiple analyses on the multitemperature structures were carried out to investigate temperature-dependent conformational changes. The structure of the SPDS-PUT complex was also solved to determine the specific role of PUT in stabilizing the gatekeeping loop in the absence of MTA or dcAdoMet. The average B-factor of the loop in the SPDS-PUT structure was compared to the average B-factors of the corresponding region in previously deposited human SPDS structures. These results improved our knowledge of the conformational changes in SPDS at near physiological temperatures and in the absence of the aminopropyl donor.
II. METHODS
A. Expression and purification
The plasmid pET-27b(+) containing SPDS gene (human) with 6× His-tag and Tobacco Etch Virus (TEV) cleavage site at the N-terminus was purchased from GenScript. Transformation of the plasmid DNA was performed using chemically competent Escherichia coli BL21 cells obtained from New England Biolabs. The cells were cultured at 37 °C to OD600 between 0.6 and 0.8 with 50 μg/ml of kanamycin in 2 × YT media and induced for SPDS expression using 1 mM IPTG (isopropyl b-D-1-thiogalactopyranoside). Post induction, the cells were incubated overnight at 15 °C and thereafter centrifuged at 6000 rpm for 45 min. The cell pellets were harvested and stored overnight at −80 °C. Resuspension of pellets was performed using a buffer containing 250 mM sodium chloride, 100 mM HEPES (2-[4-(2-hydroxyethyl) piperazin-1-yl] ethane sulfonic acid) pH 7.5, and 5 mM imidazole. The cells were lysed using a sonicator for 20 min with 20 s intermittent off pulses and subsequently centrifuged for 30 min at 21 000 rpm. The supernatant was collected and purified using a HisTrap HP Ni-NTA column (Cytiva). The running buffer remained the same as the resuspension buffer, but the elution buffer contained a higher concentration of imidazole of 250 mM. Further purification of the protein was performed using a Superdex 200 PG size-exclusion column (HiLoad 16/600, Cytiva). The buffer contained 200 mM sodium chloride and 25 mM HEPES pH 7.5.
B. Crystallization
Human SPDS with MTA and PUT was crystallized using the sitting-drop vapor diffusion method. The crystallization buffer contained 6.5%–23% polyethylene glycol 3350, 0.1 M Bis-Tris buffer, pH 5.5, and 0.05–0.225 M sodium sulfate. A concentration of 10 mg/ml of SPDS was used for crystallization, and the mixture of SPDS with MTA and PUT contained a 1:5:10 molar ratio of SPDS:MTA:PUT. SPDS with PUT was crystallized in a 1:10 molar ratio of SPDS:PUT and with a very low concentration of MTA (0.34 mM in a 1:1.13 molar ratio of SPDS to MTA). In the crystallization tray, the bottom wells contained 100 μl of mother liquor, and the top wells contained a 1:1 v/v mixture of SPDS-MTA-PUT and mother liquor. The tray was placed at room temperature, and SPDS crystals grew within 24 h. For the 100 K data, crystals were cryoprotected with 10% glycerol and plunged into liquid nitrogen. The 273 and 293 K data were collected directly at the Stanford Synchrotron Radiation Lightsource (SSRL) by adjusting the cryo-stream temperature to 273 and 293 K, respectively, before mounting the crystals. These crystals were covered with RT tubes (RT-T1 MicroRT Tubes purchased from MiTeGen) containing the mother liquor and were not cryoprotected. For SPDS-PUT data, crystals were cryoprotected with 10% glycerol and cryocooled in the cryo-stream at SSRL.
C. Data collection, processing, and refinement
Diffraction data were collected at beamline 12-1 at SSRL. SSRL auto-processing pipeline (autoPROC) was used to process data, which incorporates XDS for data reduction, POINTLESS to assign the space group, and AIMLESS for scaling/merging datasets.59–63 The AIMLESS file from autoPROC was used for Phenix (version 1.21.2-5419-000) downstream processing.64 For SPDS-PUT, data processing was carried out using DIALS within the automated xia2 pipeline,65 and POINTLESS and AIMLESS were used for space group assignment, scaling, and merging.61 To assess data quality and ensure the absence of warnings, analysis by Xtriage was performed. SPDS-PUT and 293 K datasets were solved using PDB 2O0736 as the starting structure on Phenix.refine, and the refined 293 K dataset was subsequently used to refine the 273 and 100 K datasets. R-free flags were generated for the 100 K data and SPDS-PUT data using FREERFLAG (a CCP4-supported program) to ensure 5% R-free flags were used. The generated 100 K R-free flags were transferred to 273 and 293 K, datasets using the Phenix reflection editor for consistency across all multitemperature datasets.66,67 COOT was used for manual model building (version 0.9.8.95).68 The 100, 273, and 293 K SPDS-MTA-PUT datasets were processed to 1.71, 1.98, and 1.94 Å resolution, respectively. SPDS-MTA structure was determined at 1.76 Å resolution. The data collection statistics are shown in Table I.
TABLE I.
X-ray diffraction data collection, processing, and refinement statistics.
| 100 K | 273 K | 293 K | SPDS-PUT | |
|---|---|---|---|---|
| PDB ID | 13FV | 13FW | 13FX | 13HN |
| Wavelength (Å) | 0.979 46 | 0.979 46 | 0.979 46 | 0.979 46 |
| Resolution range (Å) | 54.87–1.71 (1.80–1.71) | 54.36–1.98 (2.03–1.98) | 82.38–1.94 (2.04–1.94) | 48.86–1.76 (1.79–1.76) |
| Space group | P 1 21 1 | P 1 21 1 | P 1 21 1 | P 1 21 1 |
| Unit cell [a, b, c (Å) α, β, γ (°)] | 57.977 60.812 86.443 90 108.85 90 | 57.332 61.265 87.239 90 108.51 90 | 58.974 61.376 86.907 90 108.57 90 | 58.208 60.725 86.674 90 108.36 90 |
| Total reflections | 201 331 (29 242) | 93 803 (6670) | 117 019 (17 441) | 182 123 (10 456) |
| Unique reflections | 61 324 (8948) | 38 154 (2696) | 42 266 (6321) | 55 432 (3177) |
| Multiplicity | 3.3 (3.3) | 2.5 (2.5) | 2.8 (2.8) | 3.3 (3.3) |
| Completeness (%) | 98.8 (99.1) | 95.3 (96.7) | 96.9 (99.3) | 97.3 (97.8) |
| Mean I/sigma(I) | 6.1 (1.8) | 4.2 (1.5) | 3.9 (1) | 5.4 (1.9) |
| Wilson B-factor | 15.71 | 18.2 | 19.4 | 15.2 |
| R-merge | 0.125 (0.950) | 0.179 (1.171) | 0.149 (0.891) | 0.135 (0.716) |
| R-meas | 0.150 (1.132) | 0.221 (1.430) | 0.184 (1.104) | 0.163 (0.861) |
| R-pim | 0.081 (0.608) | 0.127 (0.809) | 0.106 (0.644) | 0.089 (0.470) |
| CC1/2 | 0.99 (0.590) | 0.981 (0.531) | 0.985 (0.457) | 0.948 (0.447) |
| Reflections used in refinement | 58 082 (2505) | 36 179 (2602) | 40 037 (2711) | 52 520 (2627) |
| Reflections used for R-free | 3207 (141) | 1941 (122) | 2153 (157) | 2758 (151) |
| R-work | 0.1706 (0.2746) | 0.1737 (0.2630) | 0.1655 (0.2618) | 0.1796 (0.2530) |
| R-free | 0.2099 (0.3156) | 0.2221 (0.3134) | 0.2066 (0.2878) | 0.2253 (0.3252) |
| Number of non-hydrogen atoms | 5125 | 4934 | 4956 | 4936 |
| Macromolecules | 4521 | 4472 | 4524 | 4439 |
| Ligands | 57 | 52 | 52 | 6 |
| Solvent | 547 | 410 | 380 | 491 |
| Protein residues | 571 | 570 | 571 | 561 |
| RMS [bonds (Å)] | 0.006 | 0.004 | 0.006 | 0.011 |
| RMS [angles (°)] | 0.82 | 0.86 | 0.88 | 0.93 |
| Ramachandran favored (%) | 97.18 | 97 | 97.53 | 97.12 |
| Ramachandran allowed (%) | 2.82 | 3 | 2.47 | 2.88 |
| Ramachandran outliers (%) | 0 | 0 | 0 | 0 |
| Rotamer outliers (%) | 0 | 0 | 0 | 0.2 |
| Clashscore | 2.1 | 1.01 | 1.1 | 2.95 |
| Average B-factor (Å2) | 22.4 | 22.25 | 24.15 | 20.15 |
| Macromolecules | 19.78 | 21.53 | 23.47 | 19.30 |
| Ligands | 24.33 | 23.25 | 27.22 | 40.22 |
| Solvent | 30.17 | 30.02 | 31.80 | 27.51 |
MTA was modeled into the active site of the SPDS-PUT structure and refined; however, the refined model showed poor agreement with experimental data (Fig. S2). The B-factors of both MTA and PUT were adjusted to match the B-factors of the neighboring residues and re-refined. The result indicated that MTA was not present in the crystal structure. In the SPDS-PUT structure, PUT occupancy was refined by first adjusting its B-factors to match those of the surrounding residues and assigning an initial occupancy of 0.5 in Coot. Occupancy refinement was then performed on Phenix by refining occupancy only. A polder omit map was also calculated using the phenix.polder on Phenix. PUT was omitted from the refined model prior to map calculation, and the resulting mFo-DFc polder map was used to assess unbiased electron density supporting ligand placement (Fig. S3). The multitemperature structures, 100, 273, and 293 K was deposited in the Protein Data Bank with PDB IDs 13FV, 13FW, and 13FX, respectively. SPDS-PUT structure was also deposited with PDB ID 13HN. Diffraction images were deposited on SBGrid Data Bank with the following DOIs: 100 K, doi:10.15785/SBGRID/1264; 273 K, doi:10.15785/SBGRID/1265; 293 K, doi:10.15785/SBGRID/1266; and SPDS-PUT, doi:10.15785/SBGRID/1268.
D. Structural analysis
Structural analysis of the multitemperature data was performed using normalized/absolute B-factors, Ringer and Flipper, the distance difference matrix (DDM), and RoPE (representation of protein entities). To compare the atomic displacement across multiple datasets, the average B-factors for all residues were normalized independently for each structure using Z-scores to account for differences in dataset quality. For each dataset, the mean residue-average B-factor was subtracted from each residue-average B-factor and divided by the standard deviation of the mean residue-average B-factor,
| (1) |
where is the average B-factor of residue , is the mean residue-average B-factor for the structure, and is the corresponding standard deviation. This normalization removes global differences in overall B-factors between datasets while preserving relative differences in residue flexibility within each structure. For comparison of loop B-factors between chains A and B within each structure (Table II), absolute average B-factors were used because both chains were refined together and therefore share the same overall B-factor scaling.
TABLE II.
Average B-factors for loop residues for new multitemperature structures and previously deposited structures.
| Average B-factors (Å2) of the loop (residues 174–185) | ||||
|---|---|---|---|---|
| Structures | Chain A | Chain B | Space group | Ligands |
| 100 K | 43.4 | 29.8 | P1211 | MTA, PUT |
| 273 K | 43.4 | 37.2 | P1211 | MTA, PUT |
| 293 K | 55 | 41.2 | P1211 | MTA, PUT |
| 2O07 | Not modeled | 31.4 | P1211 | MTA, SPD |
| 2O07_PDB_REDO | 45.6 | 34.2 | P1211 | MTA, SPD |
| 2O06 | 25.8 | 39.8 | C2221 | MTA, PUT |
| SPDS-PUT | Not modeled | 74 | P1211 | PUT |
| 2O05 | 43.1 | 41.2 | P1211 | MTA |
| 2O0L36 | Not modeled | 33 | P1211 | DcAdoMet |
| 2O0L_PDB_REDO | 56.2 | 56 | P1211 | DcAdoMet |
| 9Q41 | Not modeled | Not modeled | C2221 | apo |
Ringer and Flipper analyses were used for the detection of side chain rotamers.57,69 Ringer can detect low occupancy alternative side chain conformations, enabling comparison of side chain conformations across all multitemperature datasets. Ringer analysis was performed with mmtbx.ringer command using the PDB model and the corresponding map coefficients (map_coeffs.mtz). Map coefficients were generated from the refined model and the reflection file using phenix.maps. Ringer sampled electron density around the side chain dihedral angles from the 2mFo-DFo and mFo-DFo maps using a sigma cutoff of 0.5. The resulting Ringer outputs were analyzed using Flipper by comparing the cryogenic structure with the ambient temperature structures. Flipper is an extension of the Ringer algorithm, and it was accessed from https://github.com/TheFischerLab/Flipper,57 allowing visualization of changes in side chain conformations, including rotamer flips and conformer gains and losses, generating residue-specific plots and summary CSV files. A color-coded barcode plot of peak gains and losses was generated using Matplotlib.
The distance difference matrix (DDM) was used to compare the distances between Cα atoms.70,71 DDM analysis was performed using the ddm.py script accessed from https://github.com/malitharatnaonc/differencedistance. Pairwise Cα–Cα distances were calculated, and the differences between corresponding inter-residue distances were computed to generate DDMs for each pair of temperature datasets. Lower temperature datasets were subtracted from higher temperature datasets (D293/273K–D100K and D293–D273K). Positive DDM values indicate larger Cα–Cα distances for higher temperatures relative to the reference dataset, and shorter Cα–Cα distances are indicated by negative DDM values. The resulting matrices were exported as CSV files and visualized as heatmaps using Matplotlib.
Torsional space comparison was performed using RoPE,72 accessed from https://rope.hginn.co.uk/index.php?page=install. Newly deposited structures, 100, 273, 293 K, and SPDS-PUT, together with previously deposited structures, apoSPDS (9Q41),2 SPDS-MTA-PUT (2O06), SPDS-MTA-spermidine (SPDS-MTA-SPD) (2O07), SPDS-dcAdoMet (2O0L), SPDS-MTA (2O05),36 and SPDS-decarboxylated S-adenosylhomocysteine (SPDS-dcSAH),34 were compared based on their backbone and side chain torsion angle distributions.
III. RESULTS/DISCUSSION
The structure of human SPDS in complex with PUT was determined at a resolution of 1.76 Å. There is no electron density for MTA in this structure due to the low concentration of MTA used (Fig. S2). PUT was initially modeled in both chains; however, chain A has a much lower PUT occupancy (refined occupancy of 0.71) compared to chain B (refined occupancy of 0.84), which agrees with the calculated RSCC values of 0.55 and 0.79, respectively. A polder omit map was calculated to further validate the presence of PUT in the SPDS-PUT structure, which shows a well-defined electron density for PUT only in chain B, while the density in chain A was insufficient to confidently model PUT (Fig. S3). Therefore, PUT was removed from chain A in the final model. Comparison of the structure of the SPDS-PUT complex with the apo SPDS and other ligand-bound SPDS complexes revealed the role of ligand binding in stabilizing the gatekeeping loop. The gatekeeping loop in the structure of SPDS-PUT is highly disordered, indicating high flexibility in the absence of MTA. In a previous report, the binding of PUT stabilizes the gatekeeping as shown by the comparison of the average B-factors of the gatekeeping loop in the SPDS-MTA complex (41–43 Å2), with SPDS-MTA-PUT complex (28 Å2) and SPDS-MTA-spermidine (29 Å2).36 There is a lower B-factor in the SPDS-MTA-PUT structure compared to the SPDS-MTA structure, consistent with increased stabilization of the gatekeeping loop upon PUT binding. The normalized loop B-factors for these structures are 2.61 (chain A) and 2.44 (chain B) for SPDS-MTA, 0.57 (chain A) and 2.55 (chain B) for SPDS-MTA-PUT, and 2.67 (chain A) and 1.21 (chain B) for SPDS-MTA-SPD. The normalized average B-factor of this loop in the newly reported SPDS-PUT structure is 4.8 (74 Å2 absolute) in chain B, with no electron density for this loop in chain A, denoting the importance of MTA in stabilizing the gatekeeping loop. The SPDS-PUT structure showed a higher normalized average B-factor of the loop relative to the SPDS-MTA structure, demonstrating increased conformational flexibility. In the structure of apo SPDS (9Q41),2 the gatekeeping loop is completely disordered and therefore was not modeled, and the Asp173 catalytic residue was in an inactive conformation.2 In SPDS-PUT, the gatekeeping loop is less disordered relative to the apo structure in chain B, and the Asp173 residue is in the active conformation like other ligand-bound structures in both chains (Fig. S4). This suggests that PUT may partially occupy chain A, although the weak density did not support modeling PUT in this chain. Compared to the apo structure with the absence of electron density for the loop indicating complete disorder,2 the gatekeeping loop in the presence of either ligand is more stabilized and less flexible.
PUT interacts with Asp173 through its N1 amine, positioning it for nucleophilic attack, while Asp176 forms a hydrogen bond with the N4 amine of PUT in the SPDS-MTA-PUT (2O06) structure (Fig. 2).36 In the SPDS-MTA-SPD (2O07) structure, spermidine occupies the same binding pocket as PUT; however, the N1 amine adopts a bent conformation, whereas the N8 amine retains interaction with Asp176.36 In the SPDS-PUT structure, Asp173 forms a hydrogen bond with PUT at the N1 amine; however, there is no observed interaction between Asp176 and the N4 amine of PUT because the side chain of Asp176 lacks interpretable electron density. Consequently, the N4 amine in the SPDS-PUT structure is less constrained compared to the SPDS-MTA-PUT structure. In the SPDS-MTA structure, PUT is absent. Asp173 maintains the same active conformation, whereas Asp176 adopts a different side chain conformation in the absence of the Asp176-PUT hydrogen bond (Figs. 2 and S5). The differences in ligand interactions are accompanied by changes in the flexibility of the gatekeeping loop. The binding of both ligands contributes to the stability of the loop, with MTA responsible for much conformational order, while PUT alone does not stabilize the gatekeeping loop. Overall, the stability of the gatekeeping loop depends on the occupancy of the active site.
FIG. 2.

Interactions of PUT with Asp173 and Asp176, and the gatekeeping loop (residues 174–185) in (a) SPDS-PUT, (b) SPDS-MTA (2O05), (c) SPDS-MTA-PUT (2O06), and (d) SPDS-MTA-SPD (2O07) structures. The 2mFo-DFc map is shown in blue, contoured at an RMSD of 1.
To evaluate the differences between the multitemperature structures and the two chains of SPDS, the B-factors of the gatekeeping loop were compared (Figs. 3 and 4, and Table II). This loop exhibits different levels of conformational flexibility between the two chains across all structures. The gatekeeping loop in one chain of all structures consistently has a more ordered electron density compared to the corresponding region in the other chain. This is accompanied by lower average B-factors of the residues in this loop, indicating reduced conformational flexibility (Fig. 3 and Table II). The same trend is observed using normalized B-factors (Z scores), which accounts for differences in overall B-factor distributions between datasets (Fig. 4). In the loop region (residues 174–185), chain A consistently exhibits higher average normalized B-factors/absolute average B-factors than chain B at all temperatures (100 K: 2.44 vs 1.33 normalized, 43.4 vs 29.8 absolute; 273 K: 1.88 vs 1.12 normalized, 43.6 vs 37.2 absolute; 293 K: 2.24 vs 1.60 normalized, 55 vs 41.2 absolute), indicating greater relative flexibility of chain A. Notably, high average B-factors/normalized B-factors in the gatekeeping loop of one of the chains correlates with reduced PUT occupancy in this chain. This is consistent with the observations in the SPDS-PUT structure, where there is higher occupancy of PUT in one chain than the other. This further supports that ligand binding and occupancy influence the flexibility of the gatekeeping loop.
FIG. 3.

B-factor putty representation of SPDS at (a) 100 K (scale: 11–43), (b) 273 K (scale: 10.5–80), and (c) 293 K (scale: 11–78), showing differences in gatekeeping loop flexibility between chains A and B. Chain A consistently shows higher B-factors than chain B in the gatekeeping loop region across the three temperatures, illustrating the differences in structural flexibility.
FIG. 4.

Normalized B-factor plots of 100, 273, and 293 K Å structures. (a) Chain A. (b) Chain B. The star represents the gatekeeping loop region.
This same pattern of higher average B-factor/conformational flexibility in the gatekeeping loop of one chain relative to the other exists in the previously deposited structure of SPDS-MTA-SPD (PDB 2O07), which has the same space group (P1211) as the new structures (100, 273, and 293 K). Also, the previously deposited structure of SPDS-MTA-PUT (PDB 2O06)36 with a different space group (C2221) from the new structures has the same pattern. The catalytic residues (Asp173 and Ser174) that precede the disordered region in the gatekeeping loop in the apo human structure with space group C2221 were shown to have well-defined electron density in one chain compared to the other chain.2 In other words, this trend is observed in structures even with different space groups, with one chain consistently having a higher average loop B-factor than the other. No crystal contacts were observed near the gatekeeping loop in either chain, indicating that crystal contacts do not account for observed asymmetry (Fig. S6). The difference in flexibility of the gatekeeping loop between the two chains becomes more pronounced upon PUT binding, whereas in the absence of PUT, with only aminopropyl/MTA bound, both chains show comparable average loop B-factors. Structural asymmetry between protomers is increasingly recognized in homo-oligomeric proteins such as fluoroacetate dehalogenase, ribonucleotide reductases (RNR), and tumor necrosis factor receptor associated protein 1 (TRAP1), where the distinct conformational states of individual protomers have been linked to enzyme dynamics and catalytic regulations.73–80 Structural asymmetry was proposed to be induced by the simultaneous dimerization of the N-terminal and C-terminal domains in the homodimeric protein mitochondrial heat shock protein 90 (TRAP1), which leads to an asymmetric helix swap at the middle to the C-terminal domain.76 Asymmetry in thiamine-dependent enzymes and other homo-oligomeric enzymes, RNR and Tryptophan 2,3-dioxygenase (TDO), has been linked to distinctive catalytic characteristics, including half-of-sites reactivity and negative cooperativity.73,80 The asymmetric behavior of the gatekeeping loop between both chains of SPDS, with one consistently more ordered, suggests preferential stabilization of one active site at a time.
The 100, 273, and 293 K structures were determined to a resolution of 1.71, 1.98, and 1.94 Å, respectively. The differences between multitemperature structures of SPDS were subtle; thus, Ringer and Flipper, RoPE, and DDM were used to analyze the temperature differences between the data. Ringer and Flipper analyses were used to examine the side chain conformational heterogeneity55,57,69 at different temperatures (Figs. 5, S7, S8, and S9). The barcode plots of chi1 and chi2 show several residues with peak gains across the structures [Figs. 3(a) and 3(b)]. The results show a similar number of peak gains when the 100 K structure was compared with both the 273 K (51 vs 47 peak gains) and 293 K structures (49 and 42 peak gains) (Fig. S7). This indicates that some residues only exhibit alternate rotameric conformation at certain temperatures, and that overall heterogeneity of side chains is not increased between cryogenic and ambient temperatures. Examples of residues with alternate rotameric side chains that are detectable at cryogenic temperature are Cys205, Gln191, Ser281, and Glu208 (Fig. S8), and those that are detectable only at ambient temperatures are Ser256, Gln264, Glu158, and Ser145 (Fig. S9). The side chain alternate conformation of Ser256 is present in both chain A and B of the 273 K structures and chain A of the 293 K structure. At 100 K, the single side chain conformation of Glu158 is consistent in both chain A and chain B, while at 293 K, the conformational landscape of the residue broadens between both chains, suggesting asymmetric conformational sampling between the chains. Some residues show a shift in rotamer population at higher temperatures, such as Ser78, consistent in chain A and chain B of the 293 K structure and chain A of the 273 K structure [Fig. 5(c)]. The catalytic residue, Gln80, that interacts with the dcAdoMet aminopropyl group also appears to have an alternate side chain conformation above 0.5 sigma in both 273 and 293 K structures [Fig. 5(d)]. This alternative species would be unable to form a hydrogen bond with the amino group in dcAdoMet in this orientation. These observations reveal the heterogeneous temperature-dependent conformational sampling and redistribution of side chain rotamer populations at different temperatures, expanding our understanding of the conformational landscape beyond cryogenic temperatures.
FIG. 5.

Temperature-dependent side chain conformational sampling by Flipper and Ringer analyses. (a) and (b) Flipper barcode plots of peak gains across residues in chains A and B for (a) 293 K and (b) 273 K relative to 100 K. Color-coded lines represent electron density peaks for chi 1 and chi 2 angles. (c) and (d) Representative Ringer plots showing the 2mFo-DFc map for the side chain rotamer population of (c) Ser78 and (d) Gln80.
DDM was used to determine the conformational changes between cryogenic and ambient temperature structures. The distance difference matrices between the Cα atoms were calculated by subtracting the 100 K structure from both the 273 and 293 K structures, and the 273 K from the 293 K structure. The results show a small and widely dispersed positive signal indicating increased atomic distance in the 273 and 293 K structures with an average distance difference of 0.08 and 0.13 Å for chain A and B in the 273_100 K comparison, and 0.1 and 0.11 Å in the 293_100 K comparison (Fig. 6). In the 273_293 K DDM comparison, the average distance difference in chain A is 0.01 and in chain B is −0.02, indicating minimal backbone arrangement between the two ambient temperature structures. This suggests a global expansion of the protein as it warms up and contraction of the protein by cryocooling, which is consistent with the measured unit cell parameters (Table I). Some localized regions contract as the protein warms up, as indicated by minor blue regions from negative signals. The expansion of the protein at ambient temperature is also not uniform; residues 186–188, which have the largest deviations in the structure, are right after the gatekeeping loop region, with an average distance ranging from 0.39 to 0.68 Å [Fig. 6(g)]. This indicates an increased displacement in some specific Cα atoms at higher temperatures. The largest distance differences in the 273_100 K DDM comparison for this region correspond to residue E188 in chain A (0.38 Å) and residue E186 in chain B (0.55 Å), which are lower than the largest distance differences observed in the 293_100 K DDM comparison for this region, corresponding to residue E187 (0.56 Å in chain A and 0.68 Å in chain B). This is consistent with the 293_273 K DDM comparison, in which the largest distance differences correspond to residue E187 (0.2 Å in chain A and 0.4 Å in chain B), indicating larger distance differences in this region for the 293 K structure. These results indicate that the helix is a component of loop opening, and at elevated temperatures, favors an expanded conformation. There is also a slight difference in intensity between chain A and chain B of the compared structures, especially the loop region of the 273_100 K DDM comparison, suggesting possible asymmetry between the two chains. Overall, the interatomic distances are underestimated because of cryocooling, and higher temperatures promote coordinated backbone rearrangement by expansion of interatomic distances.
FIG. 6.

Distance difference matrix of SPDS across temperature gradients. The color scale represents distance differences (D293/273K–D100K and D293–D273K) in angstroms (Å), with red indicating an increase in distance and blue representing a decrease in distance. (a) and (b) 293 vs 100 K comparison (c) and (d) 273 vs 100 K comparison (e) and (f) 293 vs 273 K comparison. (g) Structure of SPDS showing residues (orange) with the highest average distance differences identified by DDM. The gatekeeping loop is shown in red, and ligands are in gray.
To assess the conformational differences between the new structures and previously deposited structures, RoPE72 was used for torsional space comparison (Fig. S10). This analysis revealed that ambient temperature structures sample a slightly different conformational state from the cryogenic structure, as shown by the small shift in torsional space. The 273 and 293 K structures are close together, indicating that they sample similar conformational states. Crystal packing has an influence on torsional space, as the apoSPDS structure (9Q41) and the SPDS-MTA-PUT structure (2O06), with the same space group of C2221, sample a completely different torsional region compared to other structures with the space group of P1211. The specific ligand bound to SPDS can also cause variation in torsional space. SPDS-MTA (2O05), SPDS-MTA-SPD (2O07), SPDS-dcAdoMet (2O0L), SPDS-dcSAH (3RW9), the new SPDS-PUT structure, and the 100 K SPDS-MTA-PUT structure sample different conformational space despite having the same space group, and all are cryogenic structures. The differences could also result from differences in crystal preparations because SPDS-MTA (2O05) and SPDS-MTA-SPD (2O07), with similar crystal preparations, sample similar torsional space even with different ligands bound. However, SPDS-dcAdoMet (2O0L), with the same crystal preparation as SPDS-MTA (2O05) and SPDS-MTA-SPD (2O07), samples a different torsional space from the latter two structures, suggesting the influence of specific ligand binding. Despite similar crystal preparation, SPDS-PUT also samples a distinct but similar conformational region compared to the 100 K SPDS-MTA-PUT structure, consistent with the effect of ligand composition on conformational sampling. The proximity of the two chains of SPDS structures suggests similarity in torsional space. These results demonstrate that SPDS-MTA-PUT structures collected at different temperatures sample similar torsional space, indicating that the overall protein conformation is only subtly affected by data collection temperatures. This is in contrast to AdoMetDC, a rate-limiting polyamine biosynthetic enzyme, where torsional space sampling is influenced by data collection temperatures as much as by ligand binding.21 RoPE analysis in the protein tyrosine phosphatase also demonstrated that high temperature induces a more global conformational state compared to high pressure, indicating that temperature can significantly influence protein conformational sampling.81 The separation of structures according to space group suggests that crystal packing and ligand occupancy contribute more to the observed global torsional variation than data collection temperature.
IV. CONCLUSIONS
The structure of SPDS-PUT was collected at 100 K and solved at 1.76 Å resolution. This structure reveals PUT binding in the absence of MTA and shows that PUT alone does not stabilize the gatekeeping loop, with full stabilization observed when both ligands are bound. Multitemperature structures at 100, 273, and 293 K were determined at 1.71, 1.98, and 1.94 Å resolution, respectively. Comparison of the three structures together with previously deposited structures enabled chain-specific analysis, revealing consistently higher conformational flexibility of the gatekeeping loop in one chain relative to the other chain, suggesting that one active site is preferentially stabilized. Differences between these multitemperature structures were analyzed with Flipper and Ringer, DDM, and Rope. Flipper and Ringer reveal temperature-dependent heterogenous sampling of side chain conformations. DDM analysis reveals subtle expansion of higher temperature structures of SPDS relative to the cryogenic structure, with the largest changes localized to the helix right after the gatekeeping loop. RoPE analysis demonstrates that the observed conformational variation is influenced by crystal packing and ligand binding more than by data collection temperature. Overall, this study provides new structural insights into putrescine binding and conformational heterogeneity in SPDS.
SUPPLEMENTARY MATERIAL
See the supplementary material for the following: Fig. S1: mechanism of catalysis by SPDS. Figure S2: active site of SPDS-PUT structure upon refinement with MTA. Figure S3: Polder omit map of PUT in the SPDS-PUT active site. Figure S4: superposition of SPDS-PUT structure with apo SPDS (9Q41) and SPDS-MTA-PUT (2O06) showing the conformation of the catalytic residue, Asp173. Figure S5: interactions of PUT with Asp173 and Asp176 and the gatekeeping loop. Figure S6: crystal packing environment of SPDS. Figure S7: Flipper peak gains across residues in 273 and 293 K relative to 100 K. Figure S8: Ringer plots of selected residues showing alternate rotameric side chains that are detectable at cryogenic temperatures. Figure S9: Ringer plots of selected residues showing alternate rotameric side chains that are detectable only at ambient temperatures. Figure S10: torsional space analysis of new SPDS structures and previously deposited human SPDS structures.
ACKNOWLEDGMENTS
The authors appreciate the support of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, for beamtime. “Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (P30GM133894). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.”
This research was funded by the Cancer Prevention Research Institute of Texas (CPRIT) with Grant No. RR220081. J.A.C. is also supported by NIH grant R35 GM155320. This research was supported in part by the Baylor University Molecular Biosciences Center (Waco, TX). The authors express their gratitude to all members of the Clinger Laboratory for their support and cooperation.
AUTHOR DECLARATIONS
Conflict of Interest
The authors have no conflicts to disclose.
Author Contributions
Omowumi O. Fagbohun: Conceptualization (equal); Data curation (lead); Formal analysis (lead); Investigation (equal); Methodology (lead); Validation (lead); Visualization (lead); Writing – original draft (lead); Writing – review & editing (equal). Molly A. Canfield: Conceptualization (supporting); Data curation (supporting); Investigation (supporting); Methodology (supporting). Jonathan A. Clinger: Conceptualization (equal); Funding acquisition (lead); Investigation (equal); Project administration (lead); Resources (lead); Supervision (lead); Validation (supporting); Visualization (supporting); Writing – original draft (supporting); Writing – review & editing (equal).
DATA AVAILABILITY
The data that support the findings of this study are openly available in SBGrid at http://doi.org/10.15785/SBGRID/1264, Ref. 82; SBGrid at http://doi.org/10.15785/SBGRID/1265, Ref. 83; SBGrid at http://doi.org/10.15785/SBGRID/1266, Ref. 84; and SBGrid at http://doi.org/10.15785/SBGRID/1268, Ref. 85.
References
- 1.Casero R. A. and Marton L. J., “Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases,” Nat. Rev. Drug Discovery 6(5), 373–390 (2007). 10.1038/nrd2243 [DOI] [PubMed] [Google Scholar]
- 2.Fagbohun O. O., Canfield M. A., and Clinger J. A., “Crystal structure of apo human spermidine synthase reveals dynamic rearrangement at the active site,” Struct. Dyn. 13(1), 014701 (2026). 10.1063/4.0001199 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Gerner E. W. and Meyskens F. L., “Polyamines and cancer: Old molecules, new understanding,” Nat. Rev. Cancer 4(10), 781–792 (2004). 10.1038/nrc1454 [DOI] [PubMed] [Google Scholar]
- 4.Korolev S., Ikeguchi Y., Skarina T., Beasley S., Arrowsmith C., Edwards A., Joachimiak A., Pegg A. E., and Savchenko A., “The crystal structure of spermidine synthase with a multisubstrate adduct inhibitor,” Nat. Struct. Biol. 9(1), 27–31 (2002). 10.1038/nsb737 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Li J., Meng Y., Wu X., and Sun Y., “Polyamines and related signaling pathways in cancer,” Cancer Cell Int. 20(1), 539 (2020). 10.1186/s12935-020-01545-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Pirinen E., Kuulasmaa T., Pietilä M., Heikkinen S., Tusa M., Itkonen P., Boman S., Skommer J., Virkamäki A., Hohtola E., Kettunen M., Fatrai S., Kansanen E., Koota S., Niiranen K., Parkkinen J., Levonen A.-L., Ylä-Herttuala S., Hiltunen J. K., Alhonen L., Smith U., Jänne J., and Laakso M., “Enhanced polyamine catabolism alters homeostatic control of white adipose tissue mass, energy expenditure, and glucose metabolism,” Mol. Cell. Biol. 27(13), 4953–4967 (2007). 10.1128/MCB.02034-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Yuan Q., Ray R. M., Viar M. J., and Johnson L. R., “Polyamine regulation of ornithine decarboxylase and its antizyme in intestinal epithelial cells,” Am. J. Physiol. Gastrointest. Liver Physiol. 280(1), G130–G138 (2001). 10.1152/ajpgi.2001.280.1.G130 [DOI] [PubMed] [Google Scholar]
- 8.Igarashi K. and Kashiwagi K., “Modulation of cellular function by polyamines,” Int. J. Biochem. Cell Biol. 42(1), 39–51 (2010). 10.1016/j.biocel.2009.07.009 [DOI] [PubMed] [Google Scholar]
- 9.Minois N., “Molecular basis of the ‘anti-aging’ effect of spermidine and other natural polyamines—A mini-review,” Gerontology 60(4), 319–326 (2014). 10.1159/000356748 [DOI] [PubMed] [Google Scholar]
- 10.Terui Y., Ohnuma M., Hiraga K., Kawashima E., and Oshima T., “Stabilization of nucleic acids by unusual polyamines produced by an extreme thermophile, Thermus thermophilus,” Biochem. J. 388(Pt 2), 427–433 (2005). 10.1042/BJ20041778 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wang J.-Y. and Casero R., Polyamine Cell Signaling (Springer, 2006), p. 490. [Google Scholar]
- 12.Casero R. A., Murray Stewart T., and Pegg A. E., “Polyamine metabolism and cancer: Treatments, challenges and opportunities,” Nat. Rev. Cancer 18(11), 681–695 (2018). 10.1038/s41568-018-0050-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Cervelli M., Fratini E., Amendola R., Bianchi M., Signori E., Ferraro E., Lisi A., Federico R., Marcocci L., and Mariottini P., “Increased spermine oxidase (SMO) activity as a novel differentiation marker of myogenic C2C12 cells,” Int. J. Biochem. Cell Biol. 41(4), 934–944 (2009). 10.1016/j.biocel.2008.09.009 [DOI] [PubMed] [Google Scholar]
- 14.Cervelli M., Angelucci E., Germani F., Amendola R., and Mariottini P., “Inflammation, carcinogenesis and neurodegeneration studies in transgenic animal models for polyamine research,” Amino Acids 46(3), 521–530 (2014). 10.1007/s00726-013-1572-3 [DOI] [PubMed] [Google Scholar]
- 15.Hegde S. S., Chandler J., Vetting M. W., Yu M., and Blanchard J. S., “Mechanistic and structural analysis of human spermidine/spermine N1-acetyltransferase,” Biochemistry 46(24), 7187–7195 (2007). 10.1021/bi700256z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kurata H. T., Akrouh A., Li J. B. W., Marton L. J., and Nichols C. G., “Scanning the topography of polyamine blocker binding in an inwardly rectifying potassium channel,” J. Biol. Chem. 288(9), 6591–6601 (2013). 10.1074/jbc.M112.383794 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Pegg A. E. and Casero R. A., “Current status of the polyamine research field,” Methods Mol. Biol. 720, 3–35 (2011). 10.1007/978-1-61779-034-8_1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Rossi M. N., Fiorucci C., Mariottini P., and Cervelli M., “Unveiling the hidden players: Noncoding RNAs orchestrating polyamine metabolism in disease,” Cell Biosci. 14(1), 84 (2024). 10.1186/s13578-024-01235-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Rossi M. N. and Cervelli M., “Polyamine metabolism and functions: Key roles in cellular health and disease,” Biomolecules 14(12), 1570 (2024). 10.3390/biom14121570 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ikeguchi Y., Bewley M. C., and Pegg A. E., “Aminopropyltransferases: Function, structure and genetics,” J. Biochem. 139(1), 1–9 (2006). 10.1093/jb/mvj019 [DOI] [PubMed] [Google Scholar]
- 21.Patel J. R., Bonzon T. J., Bakht T. F., Fagbohun O. O., and Clinger J. A., “Multi-temperature crystallography of S-adenosylmethionine decarboxylase observes dynamic loop motions,” Biomolecules 15(9), 1274 (2025). 10.3390/biom15091274 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Pegg A. E., “Regulation of ornithine decarboxylase,” J. Biol. Chem. 281(21), 14529–14532 (2006). 10.1074/jbc.R500031200 [DOI] [PubMed] [Google Scholar]
- 23.Murray-Stewart T. R., Woster P. M., and Casero R. A., “Targeting polyamine metabolism for cancer therapy and prevention,” Biochem. J. 473(19), 2937–2953 (2016). 10.1042/BCJ20160383 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Celano P., Baylin S. B., and Casero R. A., “Polyamines differentially modulate the transcription of growth-associated genes in human colon carcinoma cells,” J. Biol. Chem. 264(15), 8922–8927 (1989). 10.1016/S0021-9258(18)81881-6 [DOI] [PubMed] [Google Scholar]
- 25.Guo Y., Ye Q., Deng P., Cao Y., He D., Zhou Z., Wang C., Zaytseva Y. Y., Schwartz C. E., Lee E. Y., Evers B. M., Morris A. J., Liu S., and She Q.-B., “Spermine synthase and MYC cooperate to maintain colorectal cancer cell survival by repressing Bim expression,” Nat. Commun. 11(1), 3243 (2020). 10.1038/s41467-020-17067-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Tabib A. and Bachrach U., “Role of polyamines in mediating malignant transformation and oncogene expression,” Int. J. Biochem. Cell Biol. 31(11), 1289–1295 (1999). 10.1016/S1357-2725(99)00098-9 [DOI] [PubMed] [Google Scholar]
- 27.Elmets C. A. and Athar M., “Targeting ornithine decarboxylase for the prevention of nonmelanoma skin cancer in humans,” Cancer Prev. Res. 3(1), 8–11 (2010). 10.1158/1940-6207.CAPR-09-0248 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Gilmour S. K., “Polyamines and nonmelanoma skin cancer,” Toxicol. Appl. Pharmacol. 224(3), 249–256 (2007). 10.1016/j.taap.2006.11.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Gupta S., Ahmad N., Marengo S. R., MacLennan G. T., Greenberg N. M., and Mukhtar H., “Chemoprevention of prostate carcinogenesis by α-difluoromethylornithine in TRAMP mice,” Cancer Res. 60(18), 5125–5133 (2000). [PubMed] [Google Scholar]
- 30.Manni A., Grove R., Kunselman S., and Aldaz C. M., “Involvement of the polyamine pathway in breast cancer progression,” Cancer Lett. 92(1), 49–57 (1995). 10.1016/0304-3835(95)03763-M [DOI] [PubMed] [Google Scholar]
- 31.Upp J. R., Saydjari R., Townsend C. M., Singh P., Barranco S. C., and Thompson J. C., “Polyamine levels and gastrin receptors in colon cancers,” Ann. Surg. 207(6), 662–669 (1988). 10.1097/00000658-198806000-00004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Kim S. and Chang J. H., “Structural analysis of spermidine synthase from Kluyveromyces lactis,” Molecules 28(8), 3446 (2023). 10.3390/molecules28083446 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Lee M.-J., Yang Y.-T., Lin V., and Huang H., “Site-directed mutations of the gatekeeping loop region affect the activity of Escherichia coli spermidine synthase,” Mol. Biotechnol. 54(2), 572–580 (2013). 10.1007/s12033-012-9599-3 [DOI] [PubMed] [Google Scholar]
- 34.Sečkutė J., McCloskey D. E., Thomas H. J., Secrist J. A., Pegg A. E., and Ealick S. E., “Binding and inhibition of human spermidine synthase by decarboxylated S-adenosylhomocysteine,” Protein Sci. 20(11), 1836–1844 (2011). 10.1002/pro.717 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Sekula B. and Dauter Z., “Spermidine synthase (SPDS) undergoes concerted structural rearrangements upon ligand binding—A case study of the two SPDS isoforms from Arabidopsis thaliana,” Front. Plant Sci. 10, 555 (2019). 10.3389/fpls.2019.00555 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Wu H., Min J., Ikeguchi Y., Zeng H., Dong A., Loppnau P., Pegg A. E., and Plotnikov A. N., “Structure and mechanism of spermidine synthases,” Biochemistry 46(28), 8331–8339 (2007). 10.1021/bi602498k [DOI] [PubMed] [Google Scholar]
- 37.Blavid R., Kusch P., Hauber J., Eschweiler U., Sarite S. R., Specht S., Deininger S., Hoerauf A., and Kaiser A., “Down-regulation of hypusine biosynthesis in plasmodium by inhibition of S-adenosyl-methionine-decarboxylase,” Amino Acids 38(2), 461–469 (2010). 10.1007/s00726-009-0405-x [DOI] [PubMed] [Google Scholar]
- 38.Pálfi P., Bakacsy L., Kovács H., and Szepesi Á., “Hypusination, a metabolic posttranslational modification of eIF5A in plants during development and environmental stress responses,” Plants 10(7), 1261 (2021). 10.3390/plants10071261 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Tauc M., Cougnon M., Carcy R., Melis N., Hauet T., Pellerin L., Blondeau N., and Pisani D. F., “The eukaryotic initiation factor 5A (eIF5A1), the molecule, mechanisms and recent insights into the pathophysiological roles,” Cell Biosci. 11(1), 219 (2021). 10.1186/s13578-021-00733-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Wątor E., Wilk P., and Grudnik P., “Half way to hypusine—Structural basis for substrate recognition by human deoxyhypusine synthase,” Biomolecules 10(4), 522 (2020). 10.3390/biom10040522 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Bosch J. and Hol W. G. J., see https://www.rcsb.org/structure/3BWB for “Structural Genomics of Pathogenic Protozoa Consortium (SGPP), Crystal Structure of the Apo Form of Spermidine Synthase from Trypanosoma cruzi at 2.5 A Resolution” (2008).
- 42.Dufe V. T., Qiu W., Müller I. B., Hui R., Walter R. D., and Al-Karadaghi S., “Crystal structure of Plasmodium falciparum spermidine synthase in complex with the substrate decarboxylated S-adenosylmethionine and the potent inhibitors 4MCHA and AdoDATO,” J. Mol. Biol. 373(1), 167–177 (2007). 10.1016/j.jmb.2007.07.053 [DOI] [PubMed] [Google Scholar]
- 43.Tan A. Y., Smith P. C., Shen J., Xiao R., Acton T., Rost B., Montelione G., and Hunt J. F., see https://www.rcsb.org/structure/1IY9 for “Northeast Structural Genomics Consortium (NESG), Crystal Structure of Spermidine Synthase” (2002).
- 44.Wesenberg G. E., Smith D. W., G. N. Phillips, Jr., Bitto E., Bingman C. A., and Allard S. T. M., see https://www.rcsb.org/structure/1XJ5 for “Center for Eukaryotic Structural Genomics (CESG), X-ray Structure of Spermidine Synthase from Arabidopsis thaliana Gene AT1G23820” (2004).
- 45.Coureux P.-D., Fan Z. P., Stojanoff V., and Genick U. K., “Picometer-scale conformational heterogeneity separates functional from nonfunctional states of a photoreceptor protein,” Structure 16(6), 863–872 (2008). 10.1016/j.str.2008.02.022 [DOI] [PubMed] [Google Scholar]
- 46.Fraser J., van den Bedem H., Samelson A., Lang P., Holton J., Echols N., and Alber T., “Accessing protein conformational ensembles using room-temperature X-ray crystallography,” Proc. Natl. Acad. Sci. U. S. A. 108, 16247–16252 (2011). 10.1073/pnas.1111325108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Halle B., “Biomolecular cryocrystallography: Structural changes during flash-cooling,” Proc. Natl. Acad. Sci. U. S. A. 101(14), 4793–4798 (2004). 10.1073/pnas.0308315101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Keedy D. A., Fraser J. S., and van den Bedem H., “Exposing hidden alternative backbone conformations in X-ray crystallography using qFit,” PLoS Comput. Biol. 11(10), e1004507 (2015). 10.1371/journal.pcbi.1004507 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Rader S. D. and Agard D. A., “Conformational substates in enzyme mechanism: The 120 K structure of alpha-lytic protease at 1.5 A resolution,” Protein Sci. 6(7), 1375–1386 (1997). 10.1002/pro.5560060701 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Bradford S. Y. C., Khoury L. E., Ge Y., Osato M., Mobley D. L., and Fischer M., “Temperature artifacts in protein structures bias ligand-binding predictions,” Chem. Sci. 12(34), 11275–11293 (2021). 10.1039/D1SC02751D [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Deck S. L., Xu M., Milano S. K., and Cerione R. A., “Revealing functional hotspots: Temperature-dependent crystallography of K-RAS highlights allosteric and druggable sites,” bioRxiv (2025).
- 52.Fischer M., “Macromolecular room temperature crystallography,” Q. Rev. Biophys. 54, e1 (2021). 10.1017/S0033583520000128 [DOI] [PubMed] [Google Scholar]
- 53.Fischer M., Shoichet B. K., and Fraser J. S., “One crystal, two temperatures: Cryocooling penalties alter ligand binding to transient protein sites,” ChemBioChem 16(11), 1560–1564 (2015). 10.1002/cbic.201500196 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Fraser J. S., Clarkson M. W., Degnan S. C., Erion R., Kern D., and Alber T., “Hidden alternative structures of proline isomerase essential for catalysis,” Nature 462(7273), 669–673 (2009). 10.1038/nature08615 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Keedy D. A., Kenner L. R., Warkentin M., Woldeyes R. A., Hopkins J. B., Thompson M. C., Brewster A. S., Van Benschoten A. H., Baxter E. L., Uervirojnangkoorn M., McPhillips S. E., Song J., Alonso-Mori R., Holton J. M., Weis W. I., Brunger A. T., Soltis S. M., Lemke H., Gonzalez A., Sauter N. K., Cohen A. E., van den Bedem H., Thorne R. E., and Fraser J. S., “Mapping the conformational landscape of a dynamic enzyme by multitemperature and XFEL crystallography,” eLife 4, e07574 (2015). 10.7554/eLife.07574 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.McLeod M. J., Barwell S. A. E., Holyoak T., and Thorne R. E., “A structural perspective on the temperature dependent activity of enzymes,” Structure 33(5), 924–934.e2 (2025). 10.1016/j.str.2025.02.013 [DOI] [PubMed] [Google Scholar]
- 57.Stachowski T. R., Vanarotti M., Seetharaman J., Lopez K., and Fischer M., “Water networks repopulate protein–ligand interfaces with temperature,” Angew. Chem., Int. Ed. 61(31), e202112919 (2022). 10.1002/anie.202112919 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.van den Bedem H., Bhabha G., Yang K., Wright P. E., and Fraser J. S., “Automated identification of functional dynamic contact networks from X-ray crystallography,” Nat. Methods 10(9), 896–902 (2013). 10.1038/nmeth.2592 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Agirre J., Atanasova M., Bagdonas H., Ballard C. B., Baslé A., Beilsten-Edmands J., Borges R. J., Brown D. G., Burgos-Mármol J. J., Berrisford J. M., Bond P. S., Caballero I., Catapano L., Chojnowski G., Cook A. G., Cowtan K. D., Croll T. I., Debreczeni J. É., Devenish N. E., Dodson E. J., Drevon T. R., Emsley P., Evans G., Evans P. R., Fando M., Foadi J., Fuentes-Montero L., Garman E. F., Gerstel M., Gildea R. J., Hatti K., Hekkelman M. L., Heuser P., Hoh S. W., Hough M. A., Jenkins H. T., Jiménez E., Joosten R. P., Keegan R. M., Keep N., Krissinel E. B., Kolenko P., Kovalevskiy O., Lamzin V. S., Lawson D. M., Lebedev A. A., Leslie A. G. W., Lohkamp B., Long F., Malý M., McCoy A. J., McNicholas S. J., Medina A., Millán C., Murray J. W., Murshudov G. N., Nicholls R. A., Noble M. E. M., Oeffner R., Pannu N. S., Parkhurst J. M., Pearce N., Pereira J., Perrakis A., Powell H. R., Read R. J., Rigden D. J., Rochira W., Sammito M., Sánchez Rodríguez F., Sheldrick G. M., Shelley K. L., Simkovic F., Simpkin A. J., Skubak P., Sobolev E., Steiner R. A., Stevenson K., Tews I., Thomas J. M. H., Thorn A., Valls J. T., Uski V., Usón I., Vagin A., Velankar S., Vollmar M., Walden H., Waterman D., Wilson K. S., Winn M. D., Winter G., Wojdyr M., and Yamashita K., “The CCP4 suite: Integrative software for macromolecular crystallography,” Acta Crystallogr., Sect. D 79(6), 449–461 (2023). 10.1107/S2059798323003595 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Evans P., “Scaling and assessment of data quality,” Acta Crystallogr., Sect. D 62(1), 72–82 (2006). 10.1107/S0907444905036693 [DOI] [PubMed] [Google Scholar]
- 61.Evans P. R. and Murshudov G. N., “How good are my data and what is the resolution?,” Acta Crystallogr., Sect. D 69(7), 1204–1214 (2013). 10.1107/S0907444913000061 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Kabsch W., “XDS,” Acta Crystallogr., Sect. D 66(2), 125–132 (2010). 10.1107/S0907444909047337 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Vonrhein C., Flensburg C., Keller P., Sharff A., Smart O., Paciorek W., Womack T., and Bricogne G., “Data processing and analysis with the autoPROC toolbox,” Acta Crystallogr., Sect. D 67(Pt 4), 293–302 (2011). 10.1107/S0907444911007773 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Adams P. D., Afonine P. V., Bunkóczi G., Chen V. B., Davis I. W., Echols N., Headd J. J., Hung L.-W., Kapral G. J., Grosse-Kunstleve R. W., McCoy A. J., Moriarty N. W., Oeffner R., Read R. J., Richardson D. C., Richardson J. S., Terwilliger T. C., and Zwart P. H., “PHENIX: A comprehensive Python-based system for macromolecular structure solution,” Acta Crystallogr., Sect. D 66(Pt 2), 213–221 (2010). 10.1107/S0907444909052925 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Winter G., Waterman D. G., Parkhurst J. M., Brewster A. S., Gildea R. J., Gerstel M., Fuentes-Montero L., Vollmar M., Michels-Clark T., Young I. D., Sauter N. K., and Evans G., “DIALS: Implementation and evaluation of a new integration package,” Acta Crystallogr., Sect. D 74(2), 85–97 (2018). 10.1107/S2059798317017235 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Brünger A. T., “Free R value: A novel statistical quantity for assessing the accuracy of crystal structures,” Nature 355(6359), 472–475 (1992). 10.1038/355472a0 [DOI] [PubMed] [Google Scholar]
- 67.Brünger A. T., “Free R value: Cross-validation in crystallography,” Methods Enzymol. 277, 366–396 (1997). 10.1016/S0076-6879(97)77021-6 [DOI] [PubMed] [Google Scholar]
- 68.Emsley P. and Cowtan K., “Coot: Model-building tools for molecular graphics,” Acta Crystallogr., Sect. D 60(Pt 12 Pt 1), 2126–2132 (2004). 10.1107/S0907444904019158 [DOI] [PubMed] [Google Scholar]
- 69.Lang P. T., Ng H.-L., Fraser J. S., Corn J. E., Echols N., Sales M., Holton J. M., and Alber T., “Automated electron-density sampling reveals widespread conformational polymorphism in proteins,” Protein Sci. 19(7), 1420–1431 (2010). 10.1002/pro.423 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Schneider T. R., “Objective comparison of protein structures: Error‐scaled difference distance matrices,” Acta Crystallogr., Sect. D 56(6), 714–721 (2000). 10.1107/S0907444900003723 [DOI] [PubMed] [Google Scholar]
- 71.Webber A., Ratnaweera M., Harris A., Luisi B. F., and Enguéné V. Y. N., “A model for allosteric communication in drug transport by the AcrAB-TolC tripartite efflux pump,” Antibiotics 11(1), 52 (2022). 10.3390/antibiotics11010052 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Ginn H. M., “Torsion angles to map and visualize the conformational space of a protein,” Protein Sci. 32(4), e4608 (2023). 10.1002/pro.4608 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Nguyen R. C., Stagliano C., and Liu A., “Structural insights into the half-of-sites reactivity in homodimeric and homotetrameric metalloenzymes,” Curr. Opin. Chem. Biol. 75, 102332 (2023). 10.1016/j.cbpa.2023.102332 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Chen K.-W., Sun T.-Y., and Wu Y.-D., “New insights into the cooperativity and dynamics of dimeric enzymes,” Chem. Rev. 123(16), 9940–9981 (2023). 10.1021/acs.chemrev.3c00042 [DOI] [PubMed] [Google Scholar]
- 75.Kim T. H., Mehrabi P., Ren Z., Sljoka A., Ing C., Bezginov A., Ye L., Pomès R., Prosser R. S., and Pai E. F., “The role of dimer asymmetry and protomer dynamics in enzyme catalysis,” Science 355(6322), 247 (2017). 10.1126/science.aag2355 [DOI] [PubMed] [Google Scholar]
- 76.Lavery L. A., Partridge J. R., Ramelot T. A., Elnatan D., Kennedy M. A., and Agard D. A., “Structural asymmetry in the closed state of mitochondrial Hsp90 (TRAP1) supports a two-step ATP hydrolysis mechanism,” Mol. Cell 53(2), 330–343 (2014). 10.1016/j.molcel.2013.12.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Verkhivker G. M., Agajanian S., Hu G., and Tao P., “Allosteric regulation at the crossroads of new technologies: Multiscale modeling, networks, and machine learning,” Front. Mol. Biosci. 7, 136 (2020). 10.3389/fmolb.2020.00136 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Bhate M. P., Molnar K. S., Goulian M., and DeGrado W. F., “Signal transduction in histidine kinases: Insights from new structures,” Structure 23(6), 981–994 (2015). 10.1016/j.str.2015.04.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Frank R. A. W., Titman C. M., Pratap J. V., Luisi B. F., and Perham R. N., “A molecular switch and proton wire synchronize the active sites in thiamine enzymes,” Science 306(5697), 872–876 (2004). 10.1126/science.1101030 [DOI] [PubMed] [Google Scholar]
- 80.Frank R. A. W., Leeper F. J., and Luisi B. F., “Structure, mechanism and catalytic duality of thiamine-dependent enzymes,” Cell. Mol. Life Sci. 64(7), 892 (2007). 10.1007/s00018-007-6423-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Guerrero L., Ebrahim A., Riley B. T., Kim M., Huang Q., Finke A. D., and Keedy D. A., “Pushed to extremes: Distinct effects of high temperature versus pressure on the structure of STEP,” Commun. Biol. 7(1), 59 (2024). 10.1038/s42003-023-05609-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Fagbohun O. O. and Clinger J. A. (2026). “X-Ray Diffraction data for: Spermidine Synthase. PDB Code 13FV,” SBGrid Data Bank. 10.15785/SBGRID/1264 [DOI]
- 83.Fagbohun O. O. and Clinger J. A. (2026). “X-Ray Diffraction data for: Spermidine Synthase. PDB Code 13FW,” SBGrid Data Bank. 10.15785/SBGRID/1265 [DOI]
- 84.Fagbohun O. O. and Clinger J. A. (2026). “X-Ray Diffraction data for: Spermidine Synthase. PDB Code 13FX,” SBGrid Data Bank. 10.15785/SBGRID/1266 [DOI]
- 85.Fagbohun O. O. and Clinger J. A. (2026). “X-Ray Diffraction data for: Spermidine Synthase. PDB Code 13HN,” SBGrid Data Bank. 10.15785/SBGRID/1268 [DOI]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Citations
- Fagbohun O. O. and Clinger J. A. (2026). “X-Ray Diffraction data for: Spermidine Synthase. PDB Code 13FV,” SBGrid Data Bank. 10.15785/SBGRID/1264 [DOI]
- Fagbohun O. O. and Clinger J. A. (2026). “X-Ray Diffraction data for: Spermidine Synthase. PDB Code 13FW,” SBGrid Data Bank. 10.15785/SBGRID/1265 [DOI]
- Fagbohun O. O. and Clinger J. A. (2026). “X-Ray Diffraction data for: Spermidine Synthase. PDB Code 13FX,” SBGrid Data Bank. 10.15785/SBGRID/1266 [DOI]
- Fagbohun O. O. and Clinger J. A. (2026). “X-Ray Diffraction data for: Spermidine Synthase. PDB Code 13HN,” SBGrid Data Bank. 10.15785/SBGRID/1268 [DOI]
Data Availability Statement
The data that support the findings of this study are openly available in SBGrid at http://doi.org/10.15785/SBGRID/1264, Ref. 82; SBGrid at http://doi.org/10.15785/SBGRID/1265, Ref. 83; SBGrid at http://doi.org/10.15785/SBGRID/1266, Ref. 84; and SBGrid at http://doi.org/10.15785/SBGRID/1268, Ref. 85.
